Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 11:19 PM
NCT ID:
NCT03258593
Pre Assignment Details:
No participants were enrolled in Level 1, Durvalumab 1500mg Intravenous (IV) Every 4 Weeks (Q4WK) + Vicineum 20 mg, and Arm 2, Durvalumab + Vicineum at the Maximum Tolerated Dose (MTD).
Study:
NCT03258593
Study Brief:
Results Section:
NCT03258593